Mass General Brigham Ventures - aVenture Asset Manager Research
Location
Cambridge, MA, US
Founded
2008
Mass General Brigham Ventures is an early-stage venture capital firm focused on advancing life science technologies emerging from the Mass General Brigham research network. The firm invests in next-generation life science companies, typically participating in Seed, Series A, and Series B rounds. Their mission is to bring bench-to-bedside innovations to market, aiming to significantly enhance healthcare quality worldwide.
Notable portfolio companies include Abcuro, Affinia Therapeutics, and Garuda Therapeutics. Key partners leverage their deep connections within the Mass General Brigham health system to provide unique value-add services, including access to proprietary deal flow and extensive company-building expertise. This strategic approach has established Mass General Brigham Ventures as a pivotal player in the life sciences investment landscape.
Mass General Brigham Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
